Wen-bing Ding | Molecular Biology | Pioneer Researcher Award

Posted on by The Scientist

Prof. Wen-bing Ding | Molecular Biology | Pioneer Researcher Award

College of Plant Protection, Hunan Agricultural University | China

Dr. Wenbing Ding is an accomplished researcher at Hunan Agricultural University whose work has significantly advanced the molecular biology of insect physiology and sustainable pest management. His academic excellence is reflected in his global research influence, with 461 citations, 55 publications, and an h-index of 14, underscoring his growing impact within agricultural biotechnology and entomological sciences. Dr. Ding’s research centers on gene regulation, reproductive pathways, and innovative RNA interference (RNAi)-based strategies targeting major agricultural pests, particularly Chilo suppressalis and Sogatella furcifera. His recent contributions include elucidating the regulatory role of transcription factor E93 in vitellogenesis, demonstrating the reproductive disruption caused by HR3 knockdown, and exploring CRISPR/Cas9-mediated doublesex gene editing to impair fertility and sexual dimorphism advances that collectively strengthen the scientific foundation for next-generation, eco-friendly pest control technologies. Dr. Ding has also contributed to phytochemical research through the characterization of novel heterocyclic pseudoguaianolide derivatives, reflecting the breadth of his scientific versatility. With over 93 co-authors and collaborations across molecular biology, crop protection, and biochemical research communities, his work demonstrates strong interdisciplinary integration and international engagement. His publications across leading journals such as Molecular Biology Reports, Pest Management Science, Insect Biochemistry and Molecular Biology, and Phytochemistry highlight his commitment to high-impact scientific dissemination. Dr. Ding’s research contributes meaningfully to global food security by promoting molecular insights that can be translated into sustainable agricultural practices, reduced pesticide dependency, and enhanced crop resilience. His continued contributions position him as an influential and forward-looking scientist driving innovation at the interface of insect molecular genetics and sustainable pest management.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Ding, W., et al. (2025). Transcription factor E93 regulates vitellogenesis via the vitelline membrane protein 26Ab gene in Chilo suppressalis. Molecular Biology Reports. (Citations: 2)

  2. Ding, W., et al. (2025). Silencing the serine/threonine kinase Akt gene disrupts reproductive physiology in Sogatella furcifera and confers RNAi-mediated insect resistance in rice. Pest Management Science.

  3. Ding, W., et al. (2025). RNA interference knockdown of the nuclear receptor HR3 suppresses vitellogenesis in Chilo suppressalis. Molecular Biology Reports. (Citations: 1)

  4. Ding, W., et al. (2025). Doublesex knockout via CRISPR/Cas9 disrupts fertility and sexual dimorphism of wings in the rice stem borer Chilo suppressalis. Insect Biochemistry and Molecular Biology. (Citations: 0)

  5. Ding, W., et al. (2025). Heterocyclic pseudoguaianolide oligomers and seco-pseudoguaianolide derivatives from the inflorescence of Ambrosia artemisiifolia. Phytochemistry. (Citations: 1)

Caili Ma | Public Health | Research Excellence Award

Posted on by The Scientist

Ms. Caili Ma | Public Health | Research Excellence Award

Head-Nurse | The Second Xiangya Hospital Of Central South University | China 

Dr. Caili Ma is an emerging researcher whose scholarly contributions reflect a focused commitment to advancing evidence-based practice in clinical and nursing sciences. With 67 citations, 8 peer-reviewed publications, and an h-index of 4, Dr. Ma has steadily built a research portfolio that demonstrates both scientific rigor and growing global visibility. Her work spans critical themes in healthcare delivery, professional identity formation, patient-centered care, and stigma reduction within clinical education environments. Notably, her recent randomized controlled trial evaluating the “credit bank” intervention highlights her dedication to designing innovative, measurable strategies that enhance nursing students’ professional identity while addressing the pervasive issue of public stigma an area with significant implications for workforce development, healthcare quality, and long-term professional resilience. Dr. Ma’s collaborative footprint, illustrated by contributions involving more than 50 co-authors, underscores her engagement in interdisciplinary and multicenter research networks, enabling broader translational impact and methodological diversity. Her research influence extends beyond publications, contributing to ongoing discussions in clinical education reform and psychosocial determinants of healthcare performance. Although early in her academic trajectory, her work already demonstrates societal relevance by informing policies and practices aimed at strengthening the nursing workforce, improving mental and professional well-being among trainees, and fostering more inclusive healthcare environments. Through the combination of rigorous study design, collaborative scholarship, and commitment to addressing structural and interpersonal challenges in healthcare systems, Dr. Ma continues to shape a research agenda that aligns with international priorities in health education, stigma reduction, and sustainable professional development. Her growing citation profile and publication output reflect her expanding role in advancing high-quality research that bridges clinical education, behavioral science, and patient-oriented perspectives.

Profiles: Scopus | ORCID 

Featured Publications

  1. Qiu, C., Ni, X., Wang, Y., Cao, M., Li, X., Huang, Z., Chen, Q., Ma, C., & He, Y. (2025). Effects of a “credit bank” intervention on the professional identity and public stigma among nursing students: A randomized controlled trial. Nurse Education Today. Advance online publication. https://doi.org/10.1016/j.nedt.2025.106915     

 

Xue Wu | Cognitive Science | Outstanding Scientist Award

Posted on by The Scientist

Assoc. Prof. Dr. Xue Wu | Cognitive Science | Outstanding Scientist Award

Associate Professor | Peking University | China

Dr. Xue Wu is a highly active and emerging scholar whose research contributions reflect a growing impact in nursing science, healthcare safety, and clinical decision-support systems. With 621 citations, 39 publications, and an h-index of 8, her work demonstrates both productivity and increasing global relevance across interdisciplinary domains. She has contributed to the advancement of cognitive workload assessment, nursing brand development, and predictive modeling for critical care, including the integration of radiology notes and structured clinical data for early ICU readmission risk prediction. Her publications span peer-reviewed journals and collaborative multi-author studies, reflecting strong engagement with diverse research teams—evidenced by collaborations with over 80 co-authors across nursing, medical informatics, and safety management. Dr. Wu’s recent projects, including integrative and scoping reviews on safety-related cognitive workload and professional identity in nursing, reinforce her commitment to strengthening healthcare systems through evidence-based analysis. Her work emphasizes methodological rigor, interdisciplinary synthesis, and the development of tools that enhance patient safety, workforce identity, and clinical outcomes. Through her contributions to predictive analytics and safety frameworks, she supports the transformation of healthcare environments into more adaptive, data-informed, and patient-centered systems. Dr. Xue Wu’s research trajectory continues to contribute meaningfully to the global nursing and healthcare community, advancing knowledge that informs policy, technology design, and clinical practice.

Profiles: Scopus | ResearchGate

Featured Publications

  1. Feng, T., Huang, L., Peng, X., & Wu, X. (2025). An integrative review of cognitive workload assessment for safety management. BMC Nursing.

  2. Ge, H., Hu, H., Li, J., & Wu, X. (2025). Development of a professional profile for enhancing nursing brand image: A scoping review. International Nursing Review.

  3. Hu, H., Ma, L., Ge, H., & Wu, X. (2025). ReAdmit: Predicting early unplanned ICU readmission using radiology notes and structured data. Nursing in Critical Care.

  4. Hu, H., Teng, H., Bai, L., & Wu, X. (2025). Effect of interference on nurses in using nursing information system: A field-based eye tracking study. In Nursing Informatics Research (Book chapter).

  5. Ge, H., Feng, T., Hu, H., & Wu, X. (2025). Profiling learning styles and strategies of nursing students: A cluster analysis study. Nurse Education Today.

Yinfeng Yang | Artificial Intelligence | Research Excellence Award

Posted on by The Scientist

Assoc. Prof. Dr. Yinfeng Yang | Artificial Intelligence | Research Excellence Award

Deputy Director | School of Medical Informatics Engineering, Anhui University of Chinese Medicine | China

Dr. Yinfeng Yang is a distinguished researcher at Anhui University of Chinese Medicine, known for impactful contributions at the interface of traditional Chinese medicine, molecular pharmacology, and bioinformatics-driven disease mechanism analysis. His academic influence is demonstrated by 5,738 citations, 45 publications, and an h-index of 18, underscoring his growing global recognition in biomedical research. Dr. Yang’s work spans cancer biology, immunometabolism, and natural-product-based therapeutics, with recent studies exploring the clinicopathological relevance of BRCA1 in gastric cancer, mitochondrial pathways in rheumatoid arthritis, and angiogenesis-targeting mechanisms of Ginkgo biloba leaves. His research integrates advanced computational tools, systems pharmacology, and machine learning to decode complex biological networks and accelerate drug discovery particularly in ADMET prediction and precision therapeutic strategies. With more than 120 co-authors and interdisciplinary collaborations across oncology, pharmacology, and traditional medicine, Dr. Yang has built a broad scientific network that strengthens the translational potential of his findings. His publications in high-impact journals and open-access platforms contribute to global knowledge accessibility while supporting evidence-based modernization of traditional Chinese medicine. Dr. Yang’s work carries clear societal relevance, offering novel insights for developing safer, more effective treatments for chronic inflammatory diseases and gastrointestinal cancers. His sustained research output and increasing citation impact position him as a valuable contributor to global biomedical innovation and integrative medicine research.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Ru, J., Li, P., Wang, J., Zhou, W., Li, B., Huang, C., Li, P., Guo, Z., Tao, W., Yang, Y., … (2014). TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. Journal of Cheminformatics, 6(1), 13. Cited by: 5,020

  2. Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., & Wang, J. (2022). The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Frontiers in Oncology, 12, 985363. Cited by: 876

  3. Yang, Y., Li, Y., Wang, J., Sun, K., Tao, W., Wang, Z., Xiao, W., Pan, Y., Zhang, S., … (2017). Systematic investigation of Ginkgo biloba leaves for treating cardio-cerebrovascular diseases in an animal model. ACS Chemical Biology, 12(5), 1363–1372. Cited by: 99

  4. Li, Y., Gao, W., Li, F., Wang, J., Zhang, J., Yang, Y., Zhang, S., & Yang, L. (2013). An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine-type CDK2 inhibitors. Molecular BioSystems, 9(9), 2266–2281. Cited by: 53

  5. Li, Y., Wang, J., Xiao, Y., Wang, Y., Chen, S., Yang, Y., Lu, A., & Zhang, S. (2015). A systems pharmacology approach to investigate the mechanisms of action of Semen Strychni and Tripterygium wilfordii Hook F for treatment of rheumatoid arthritis. Journal of Ethnopharmacology, 175, 301–314. Cited by: 51

Yanan Yang | Pharmaceutical Sciences | Research Excellence Award

Posted on by The Scientist

Ms. Yanan Yang | Pharmaceutical Sciences | Research Excellence Award

Student | Tianjin University of Traditional Chinese Medicine | China

Dr. Yanan Yang is a researcher at Tianjin University of Traditional Chinese Medicine, recognized for her contributions at the intersection of gut microbiota, metabolic regulation, and cardiometabolic diseases. Her scholarly influence is demonstrated by 726 citations, 45 peer-reviewed publications, and an h-index of 14, underscoring her growing impact in biomedical and translational health research. Dr. Yang’s work spans gut microbiome dynamics, microbial metabolites, metabolic disorders, traditional Chinese medicine mechanisms, and multi-omics integration. She has contributed to high-visibility studies on acute coronary syndrome, cardiovascular disease mechanisms, type 2 diabetes regulation, and herbal-medicine-induced metabolic modulation. Her involvement in multi-center collaborations—including meta-analyses with large participant cohorts—reflects her ability to bridge clinical findings with microbiome-mediated insights. Dr. Yang’s publications highlight a consistent focus on understanding microbial signatures, therapeutic pathways, and host–microbe interactions to advance preventive and precision medicine. She has also engaged in studies evaluating herbal interventions such as Coptis chinensis, showcasing the integration of traditional medicine with modern biomedical evidence. With over 223 co-authors across her publication record, her collaborative networks extend nationally and internationally, supporting multidisciplinary innovation in gut–heart metabolic axis research. Dr. Yang’s ongoing contributions provide essential foundations for developing microbiome-based diagnostics, therapeutic strategies for metabolic diseases, and evidence-based applications of traditional Chinese medicine, reflecting her role as an emerging and influential scientist in her field.

Featured Publications

  1. Wu, C., Zhao, Y., Zhang, Y., Yang, Y., Su, W., Yang, Y., Sun, L., Zhang, F., Yu, J., … (2022). Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates prediction of BBR’s cholesterol-lowering efficacy in patients. Journal of Advanced Research, 37, 197–208. Cited by: 78

  2. Dong, C., Yang, Y., Wang, Y., Hu, X., Wang, Q., Gao, F., Sun, S., Liu, Q., Li, L., Liu, J., … (2023). Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction compared with stable coronary artery disease. Journal of Advanced Research, 46, 101–112. Cited by: 74

  3. Dong, C., Yu, J., Yang, Y., Zhang, F., Su, W., Fan, Q., Wu, C., & Wu, S. (2021). Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion. Biomedicine & Pharmacotherapy, 139, 111595. Cited by: 74

  4. Yang, Y. N., Wang, Q. C., Xu, W., Yu, J., Zhang, H., & Wu, C. (2022). The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet-induced hyperlipidemia and stimulates liver LDLR expression. Biomedicine & Pharmacotherapy, 155, 113749. Cited by: 60

  5. Xu, W., Yu, J., Yang, Y., Li, Z., Zhang, Y., Zhang, F., Wang, Q., Xie, Y., Zhao, B., & Wu, C. (2023). Strain-level screening of human gut microbes identifies Blautia producta as a new anti-hyperlipidemic probiotic. Gut Microbes, 15(1), 2228045. Cited by: 57

Ping Yang | Social Science Research | Research Excellence Award

Posted on by The Scientist

Prof. Dr. Ping Yang | Social Science Research | Research Excellence Award

Business School | Tianjin University of Finance and Economics | China

Dr. Yang Ping is a distinguished scholar in digital marketing and social media behavior, recognized for her growing global research influence and contributions to emerging areas of digital responsibility and intelligent communication. Her academic productivity reflects a strong upward trajectory, with 91 citations from 89 documents, 8 publications indexed, and an h-index of 5, underscoring her rising impact in marketing and consumer behavior research. Dr. Yang has published in leading international journals such as Personality and Individual Differences, International Journal of Consumer Studies, International Journal of Contemporary Hospitality Management, and Marketing Intelligence & Planning, alongside influential works in high-impact Chinese journals, demonstrating both international reach and domestic leadership. Her research has advanced understanding of corporate digital responsibility, prosocial behavior in anonymous online environments, and experiential outcomes in tourism and hospitality, contributing new theoretical insights and practical implications for digital platforms and consumer engagement. She has collaborated extensively with scholars across Australia, Finland, China, and the United States, producing interdisciplinary work that bridges marketing, tourism, psychology, and digital communication. As Principal Investigator and research contributor to multiple funded projects at municipal, provincial, and national levels, she has played a key role in shaping the discourse on platform governance, digital ethics, and machine-learning-driven marketing strategies. Her scholarship provides actionable guidance for enterprises navigating digital transformation, offering significant societal value by promoting responsible data practices, enhancing user well-being, and informing public policy development in the digital economy.

Profiles: Scopus | ResearchGate

Featured Publications

1. Yang, P., Ji, C., Prentice, C., & Peng, Z. (2025). Scale development and validation of corporate digital responsibility- A consumer perspective. International Journal of Consumer Studies. Citations: 5

2. Yang, P., Chunli, J., Prentice, C., & Peng, Z. (2025). Scale development and validation of corporate digital responsibility- A consumer perspective. Journal of Consumer Studies.

3. Sthapit, E., Ji, C., Yang, P., & Woosnam, K. (2024). Memorable digital-free tourism experiences: Antecedents and outcomes. Journal of Vacation Marketing. Citations: 12

4. Sthapit, E., Chunli, J., Yang, P., & Woosnam, K. M. (2024). Memorable digital-free tourism experiences: Antecedents and outcomes. Journal of Vacation Marketing.

5. Sthapit, E., Prentice, C., Ji, C., Yang, P., & Björk, P. (2024). Experience-driven well-being and purchase: An alternative model of memorable wine tourism experiences. International Journal of Tourism Research. Citations: 22

Nicolò Colistra | Mathematical Sciences | Research Excellence Award

Posted on by The Scientist

Dr. Nicolò Colistra | Mathematical Sciences | Research Excellence Award

Ricercatore | ENEA | Italy 

Dr. Nicolò Colistra is a biomedical engineer and AI researcher whose work integrates machine learning, biomedical sensing, and intelligent systems to advance healthcare diagnostics, treatment optimization, and human performance assessment. His research spans artificial intelligence for oncology and cardiology, predictive modeling for clinical decision-making, and the development of multi-scale digital twin architectures. He has contributed to high-impact innovations in cardiotoxicity assessment through big-data pipelines, automated drug-screening platforms, and advanced signal-processing algorithms, alongside significant achievements in microfabrication, biosensor design, optical systems, and clean-room prototyping. His applied research also includes the engineering of wearable and robotic systems for gait analysis, athletic performance prediction, and human–machine interaction. Dr. Colistra’s academic influence is demonstrated by 187 citations, 11 publications, and an h-index of 6, underscoring his growing visibility in biomedical engineering, AI-driven health technologies, and translational innovation. He has collaborated with leading institutions including ENEA, the University of Rome Tor Vergata, the Italian Institute of Technology, and IBM Research, contributing to multidisciplinary projects that bridge engineering, medicine, and computational sciences. His work has been showcased at major international conferences, reflecting global engagement in biomedical imaging, electroporation, bioengineering, and neurosensor technologies. Through the integration of AI, advanced sensing, and multi-disciplinary engineering, Dr. Colistra’s research contributes to safer drug development, improved cardiovascular risk evaluation, enhanced athlete monitoring, and more precise diagnostic pathways, ultimately supporting societal goals of better healthcare, prevention, and performance optimization.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  • Crusi, R., Colistra, N., Camera, F., Monti, G., Zappatore, M. S., Merla, C., & Tarricone, L. (2025). Cardiac pulsed-field ablation: Deep learning solutions for multi-parameter predictions. IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology.

  • Colistra, N., Manzi, V., Maikano, S., Laterza, F., D’Onofrio, R., & Verrelli, C. M. (2025). A new linear two-state dynamical model for athletic performance prediction in elite-level soccer players. Mathematics.

  • Iachetta, G., Melle, G., Colistra, N., Tantussi, F., De Angelis, F., & Dipalo, M. (2023). Long-term in vitro recording of cardiac action potentials on microelectrode arrays for chronic cardiotoxicity assessment. Archives of Toxicology.

  • Iachetta, G., Melle, G., Colistra, N., Tantussi, F., De Angelis, F., & Dipalo, M. (2022). Chronic cardiotoxicity assessment by cell optoporation on microelectrode arrays. bioRxiv.

  • Iachetta, G., Colistra, N., Melle, G., Deleye, L., Tantussi, F., De Angelis, F., & Dipalo, M. (2021). Improving reliability and reducing costs of cardiotoxicity assessments using laser-induced cell poration on microelectrode arrays. Toxicology and Applied Pharmacology.